Skip to main content
Article
Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy.
Annals of Surgical Oncology (2004)
  • Hiroya Takeuchi, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California
  • Bret Taback, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California
  • Christine Kuo, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California
  • Dave S. B. Hoon
Publication Date
March 1, 2004
DOI
10.1007/BF02523620
Citation Information
Hiroya Takeuchi, Bret Taback, Christine Kuo and Dave S. B. Hoon. "Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy." Annals of Surgical Oncology Vol. 11 (2004)
Available at: http://works.bepress.com/dave-hoon/279/